Where does Zhejiang Orient Gene Biotech Co., Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zhejiang Orient Gene Biotech Co., Ltd ranks #3,521 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zhejiang Orient Gene Biotech Co., Ltd hold?

Zhejiang Orient Gene Biotech Co., Ltd holds 105 US utility patents granted between 2018 and 2025, spanning 6 technology areas.

What is Zhejiang Orient Gene Biotech Co., Ltd's Innovation Score?

Zhejiang Orient Gene Biotech Co., Ltd has an Innovation Score of 46.4 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Zhejiang Orient Gene Biotech Co., Ltd's patent grant rate increasing or decreasing?

Zhejiang Orient Gene Biotech Co., Ltd's recent grant velocity is +4000% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Zhejiang Orient Gene Biotech Co., Ltd's patents?

Zhejiang Orient Gene Biotech Co., Ltd's patents average 2.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zhejiang Orient Gene Biotech Co., Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Zhejiang Orient Gene Biotech Co., Ltd

Q: What technology areas does Zhejiang Orient Gene Biotech Co., Ltd focus on?

Zhejiang Orient Gene Biotech Co., Ltd's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 10 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 105 granted patents across 6 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zhejiang ranks #3,521 of 49,997 tracked US assignees by granted-patent volume, with 105 patents across 6 technology areas.

#3,521
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.4/100): 2.7
avg claims per patent: +4000%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3521 · Foreign Corporation #3,521 · 105 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 105 grants
TOP-DECILE #3,521/49,997
PHOTO-FINISH Valencell
CPC-NARROW G01N · 6 areas
INNOV-PAR 46.4/100
CLAIMS-SPARSE 2.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +4000% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valencell, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bluestar Silicones… · near

46
Markem-Imaje · near

46
Sundance Spas · near

46
VLT · near

46
Zhejiang Orient… · this assignee

46
3D Lighting… · lowest

7

What this shows Zhejiang's Innovation Score is 46.4/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Zhejiang's grants concentrate

Zhejiang Orient Gene Biotech Co., Ltd is a focused PatentsView assignee: 6 CPC subclasses with 9.5% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (36 grants) versus a trough of 1 in 2018. By volume, Zhejiang sits between Varex Imaging Corporation and Axcelis Technologies, Inc..

Zhejiang's three-year grant acceleration

Zhejiang Orient Gene Biotech Co., Ltd shows 70 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Varex Imaging

105
Valencell

105
Versitech

105
Xiamen Leedarson…

105
Zhejiang Orient G… ◀

105
ADC Telecommunica…

104
Apparatus

104
Aptar Radolfzell

104
Axcelis

104

What this shows Zhejiang holds 105 patents at rank #3,521, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zhejiang

By rank, the assignees closest to #3,521 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Zhejiang's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zhejiang, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (46 here).

VLT, Inc. 46 Markem-Imaje Corporation 46 Bluestar Silicones France SAS 46 Sundance Spas, Inc. 46

Similar claim depth

Nearest assignees by average claims per patent (2.7 here).

Arktura LLC 2.7 avg Direct Pack, Inc. 2.7 avg Tomy Company, Ltd. 2.7 avg LaCrosse Footwear, Inc. 2.8 avg

Zhejiang's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Zhejiang Orient Gene Biotech Co., Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	1.0%
2019	1	1.0%
2020	2	1.9%
2021	10	9.5%
2022	6	5.7%
2023	28	26.7%
2024	36	34.3%
2025partial year	21	20.0%

Which technologies does Zhejiang Orient Gene Biotech Co., Ltd patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 9

A61B - DIAGNOSIS; SURGERY; Identification 4

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

G06V - Image OR Video Recognition OR Understanding 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#3,521

of 49,997 tracked assignees

Innovation Score

46.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Zhejiang Orient Gene Biotech Co., Ltd's patent record in context - here's where to go next.

Zhejiang Orient Gene Biotech Co., Ltd's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 9.5% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #3,521 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zhejiang Orient Gene Biotech Co., Ltd against Varex Imaging Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.